Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics - 26 Year Stock Price History | UTHR

Historical daily share price chart and data for United Therapeutics since 1999 adjusted for splits and dividends. The latest closing stock price for United Therapeutics as of June 13, 2025 is 283.35.
  • The all-time high United Therapeutics stock closing price was 410.00 on November 08, 2024.
  • The United Therapeutics 52-week high stock price is 417.81, which is 47.5% above the current share price.
  • The United Therapeutics 52-week low stock price is 266.98, which is 5.8% below the current share price.
  • The average United Therapeutics stock price for the last 52 weeks is 338.07.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
United Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 323.3517 360.2200 380.7800 276.4700 283.3500 -19.69%
2024 299.9294 227.3500 410.0000 210.7600 352.8400 60.46%
2023 232.1971 273.3200 276.1700 205.1900 219.8900 -20.93%
2022 217.6418 210.6300 280.4300 166.1600 278.0900 28.70%
2021 187.8557 153.9400 216.0800 153.9400 216.0800 42.35%
2020 112.2631 87.6600 151.7900 79.3900 151.7900 72.33%
2019 94.3843 107.6500 126.8400 74.8500 88.0800 -19.12%
2018 119.0494 151.9400 151.9400 101.1400 108.9000 -26.39%
2017 132.6931 143.9900 168.4200 114.6000 147.9500 3.15%
2016 121.3932 155.5400 155.5400 98.3300 143.4300 -8.42%
2015 159.5798 127.7300 188.5600 119.5700 156.6100 20.94%
2014 107.7093 110.9000 136.1600 86.1400 129.4900 14.51%
2013 71.3023 53.8300 114.5100 51.6400 113.0800 111.68%
2012 49.7618 47.8200 58.9100 40.4200 53.4200 13.06%
2011 55.0255 64.3600 70.7000 37.2100 47.2500 -25.26%
2010 55.3641 53.4400 64.2400 46.2200 63.2200 20.08%
2009 40.0159 32.0550 52.8800 27.8550 52.6500 68.35%
2008 45.0498 49.5450 57.9900 24.5050 31.2750 -35.94%
2007 34.1974 26.6100 54.3100 23.9350 48.8250 79.60%
2006 29.1060 34.2450 35.6650 23.9800 27.1850 -21.34%
2005 28.5430 22.0250 38.9100 20.6850 34.5600 53.09%
2004 14.2425 11.7400 23.3650 10.2550 22.5750 96.73%
2003 9.6684 8.5500 12.3250 7.3500 11.4750 37.43%
2002 6.7551 5.1250 8.8050 4.5500 8.3500 60.42%
2001 6.2157 7.0625 9.0000 4.3800 5.2050 -29.42%
2000 35.8713 26.5625 64.2500 6.5313 7.3750 -67.93%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.907B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $75.160B 28.04
Takeda Pharmaceutical (TAK) Japan $48.970B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.728B 24.46
BeOne Medicines - (ONC) Cayman Islands $30.278B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.478B 0.00
Merck (MKKGY) Germany $17.344B 12.71
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.530B 14.56
Neurocrine Biosciences (NBIX) United States $12.372B 42.38
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.548B 61.36
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.599B 0.00
Grifols, S.A (GRFS) Spain $6.174B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.669B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.042B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.012B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.963B 10.38
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
NewAmsterdam Pharma (NAMS) Netherlands $2.361B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.176B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.102B 0.00
Indivior (INDV) United States $1.921B 8.15
Dyne Therapeutics (DYN) United States $1.644B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.608B 0.00
Evotec AG (EVO) Germany $1.577B 0.00
Ocular Therapeutix (OCUL) United States $1.426B 0.00
ARS Pharmaceuticals (SPRY) United States $1.414B 0.00
Guardian Pharmacy Services (GRDN) United States $1.282B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.112B 22.24
Enliven Therapeutics (ELVN) United States $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Avadel Pharmaceuticals (AVDL) Ireland $0.904B 0.00
Ardelyx (ARDX) United States $0.890B 0.00
Cronos Group (CRON) Canada $0.768B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Xeris Biopharma Holdings (XERS) United States $0.691B 0.00
Xencor (XNCR) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Relay Therapeutics (RLAY) United States $0.591B 0.00
AleAnna (ANNA) United States $0.586B 0.00
Altimmune (ALT) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.563B 0.00
Regulus Therapeutics (RGLS) United States $0.559B 0.00
USANA Health Sciences (USNA) United States $0.555B 12.06
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Liminatus Pharma (LIMN) United States $0.528B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
Tourmaline Bio (TRML) United States $0.511B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.402B 0.00
Savara (SVRA) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 10.29
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Heron Therapeutics (HRTX) United States $0.307B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.49
ProKidney (PROK) United States $0.262B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.238B 0.00
MediWound (MDWD) Israel $0.220B 0.00
OmniAb (OABI) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.175B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.109B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.108B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Champions Oncology (CSBR) United States $0.102B 16.81
Wellgistics Health (WGRX) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 65.11
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Nutriband (NTRB) United States $0.085B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Surrozen (SRZN) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
China SXT Pharmaceuticals (SXTC) China $0.032B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
BioVie (BIVI) United States $0.022B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00